Cellosaurus A549-hACE2 [Invivogen] (CVCL_A5KA)
Cell line name | A549-hACE2 [Invivogen] | |
---|---|---|
Accession | CVCL_A5KA | |
Resource Identification Initiative | To cite this cell line use: A549-hACE2 [Invivogen] (RRID:CVCL_A5KA) | |
Comments | Group: SARS-CoV-2 research cell line. Population: Caucasian. Characteristics: Permissive to infection by SARS-CoV-2 and/or spike-pseudotyped lentiviral particles (InvivoGen). Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:13557; ACE2. Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P13249; S.alboniger pac (PuroR). Derived from site: In situ; Lung; UBERON=UBERON_0002048. | |
Sequence variations |
| |
Disease | Lung adenocarcinoma (NCIt: C3512) | |
Species of origin | Homo sapiens (Human) (NCBI Taxonomy: 9606) | |
Hierarchy | Parent: CVCL_0023 (A-549) Children:
| |
Sex of cell | Male | |
Age at sampling | 58Y | |
Category | Cancer cell line | |
Web pages | https://www.invivogen.com/a549-ace2-tmprss2-cells | |
Cross-references | ||
Cell line databases/resources | cancercelllines; CVCL_A5KA | |
Encyclopedic resources | Wikidata; Q107113335 | |
Entry history | ||
Entry creation | 20-May-2021 | |
Last entry update | 19-Dec-2024 | |
Version number | 7 |